Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
04/2010
04/06/2010US7692028 for treating neurological disorders such as epilepsy, neuropathic pain, bipolar disorder or migraine; 2-(2-oxo-4-propyl-1-pyrrolidinyl)butanamide; neuroprotective agent
04/06/2010US7691973 GFRα3 polypeptides
04/06/2010US7691894 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability
04/06/2010US7691883 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis
04/06/2010US7691858 3-(2,4-Diaminopteridin-6-yl)phenol or 6-(1H-Indol-4-yl)pteridine-2,4-diamine;phosphoinositide 3-kinase; enzyme inhibitors; vasculostatic agents; antiinflammatory agents; antiarthric agents; transplant rejecction; autoimmune diseases; anticarcinogenic agents
04/06/2010US7691593 Regulation of lung tissue by patched therapeutics and formulations and uses related thereto
04/06/2010US7691566 Compositions and methods for treatment of cancer
04/06/2010CA2459009C Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders
04/06/2010CA2455181C Benzimidazo[4,5-f]isoquinolinone derivatives
04/06/2010CA2453383C Piperidine derivatives as nmda receptor antagonists
04/06/2010CA2271952C Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
04/01/2010WO2010037054A2 Heteroaryl antagonists of prostaglandin d2 receptors
04/01/2010WO2010036938A2 Nanoemulsion therapeutic compositions and methods of using the same
04/01/2010WO2010036876A2 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
04/01/2010WO2010035806A1 Solid pharmaceutical composition
04/01/2010WO2010035769A1 Improved antibody molecule
04/01/2010WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient
04/01/2010WO2010035675A1 Immunopotentiator or antiallergic agent
04/01/2010WO2010035299A1 Use of triterpenic and anthraquinone glycosides as substances exerting hydragogue activity on mucosa of the upper respiratory tract, for the treatment of upper respiratory tract diseases
04/01/2010WO2010035221A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010035220A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010035217A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010034996A1 Crystalline acid addition salts and their use as enzyme inhibitors
04/01/2010WO2010034799A1 3h-imidaz0 [4, 5-b] pyridine- 6 -carboxamides as anti -inflammatory agents
04/01/2010WO2010034798A1 3h-imidazo [4, 5-c] pyridine-6-carboxamides as anti -inflammatory agents
04/01/2010WO2010034797A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents
04/01/2010WO2010034796A1 1h-benz imidazole-5-carboxamides as anti-inflammatory agents
04/01/2010WO2010034707A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
04/01/2010WO2010034706A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
04/01/2010WO2010034693A1 Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromes
04/01/2010WO2010016965A9 Methods for treating injury associated with exposure to an alkylating species
04/01/2010WO2009154800A3 Compositions and methods for treating lung disorders
04/01/2010WO2009143064A3 Rice bran extracts for inflammation and methods of use thereof
04/01/2010WO2009138762A3 Therapeutic use of peptides
04/01/2010WO2008139845A8 Novel amide derivative
04/01/2010US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products
04/01/2010US20100081696 Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
04/01/2010US20100081692 Novel 1-Benzyl-4-Piperidinamines that are Useful in the Treatment of COPD and Asthma
04/01/2010US20100081673 Heteroaryl antagonists of prostaglandin d2 receptors
04/01/2010US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
04/01/2010US20100081657 Quinoxalines useful as inhibitors of protein kinases
04/01/2010US20100081652 Cinnamoyl Compound and Use Thereof
04/01/2010US20100081645 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
04/01/2010US20100080824 A formulation comprising a cell culture extract of an isolated virus is identified to be morphologically and phylogenetically similar to the known member of coronaviruses; kits comprising containers containing the formulation used in medical diagnosis, as vaccines and antibodies
04/01/2010US20100080814 NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS
04/01/2010US20100080812 Antibodies against human IL17 and uses thereof
04/01/2010US20100080786 Phenyl or Pyridinyl Substituted Indazoles Derivatives
04/01/2010CA2738245A1 Nanoemulsion therapeutic compositions and methods of using the same
04/01/2010CA2738147A1 Solid pharmaceutical composition
04/01/2010CA2738083A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents
04/01/2010CA2737839A1 3h-imidazo [4, 5-c] pyridine-6-carboxamides as anti-inflammatory agents
04/01/2010CA2737739A1 Heteroaryl antagonists of prostaglandin d2 receptors
04/01/2010CA2737552A1 3h-imidazo [4,5-b] pyridine-6-carboxamides as anti-inflammatory agents
04/01/2010CA2737384A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents
03/2010
03/31/2010EP2169060A1 Novel polypeptide useful for diagnosis and treatment of cancer
03/31/2010EP2168984A1 Human antibodies that bind human IL-12 and methods for producing
03/31/2010EP2168968A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
03/31/2010EP2168960A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
03/31/2010EP2168959A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
03/31/2010EP2168958A1 Isoindole-Imide Compounds, Compositions And Uses Thereof
03/31/2010EP2167662A2 Pharmaceutical compounds comprising abasic oligonucleotides
03/31/2010EP2167470A1 Triazolo [1, 5-a]quinolines as adenosine a3 receptor ligands
03/31/2010EP2167102A2 Use of hyaluronic acid for preparing compositions particularly for improving the function of skin, eye and mucous membrane protection
03/31/2010EP2167099A2 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
03/31/2010EP2167092A2 Quinazoline derivatives as pi3 kinase inhibitors
03/31/2010EP2167042A2 Pharmaceutical aerosol compositions comprising fluticasone
03/31/2010EP1630165B1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
03/31/2010EP1333823B1 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
03/31/2010CN101687883A modulators of cystic fibrosis transmembrane conductance regulator
03/31/2010CN101687868A morphinan compounds
03/31/2010CN101687851A organic compounds
03/31/2010CN101687850A Substituted pyrimidines as adenosine receptor antagonists
03/31/2010CN101687842A modulators of cftr
03/31/2010CN101687826A salts of a selective beta-2 andrenoceptor agonist
03/31/2010CN101687014A compositions and methods for treating pathologic angiogenesis and vascular permeability
03/31/2010CN101687006A reconstituted surfactants having improved properties
03/31/2010CN101686996A Sulphated xylans for treatment or prophylaxis of respiratory diseases
03/31/2010CN101686955A Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders
03/31/2010CN101684147A moraxella catarrhalis proteins
03/31/2010CN101684091A cannabinoid receptor ligands
03/31/2010CN101683527A Compound preparation for treating cold and preparation method thereof
03/31/2010CN101683501A Traditional Chinese medicine composition for treating faucitis of horses
03/31/2010CN101683476A Taditional Chinese medicine preparation for treating throat edema pain
03/31/2010CN101683424A Application of Chinese medicine composition in preparation of medicament for treating tonsillitis
03/31/2010CN101683422A Applications of traditional Chinese medicine composition in preparation of medicament for treating cough variant asthma
03/31/2010CN101683421A Applications of traditional Chinese medicine composition in preparation of medicament for treating repetitive respiratory tract infection
03/31/2010CN101683420A Applications of traditional Chinese medicine composition in preparation of medicament for treating acute pharyngitis
03/31/2010CN101683412A Chinese medicine patch for treating children's bronchus asthma and method for producing the same
03/31/2010CN101683398A Traditional Chinese medicine prescription for treating body continuous external infection chill
03/31/2010CN101683396A Extraction method of tropaeolum total lavonoids
03/31/2010CN101683349A Compound florfenicol powder for treating mycoplasma of pigeon and preparation method thereof
03/31/2010CN101683334A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
03/31/2010CN101683330A Oral compound pharmaceutic preparation containing tranilast and salbutamol
03/31/2010CN101683325A Cydiodine buccal tablets and preparation method thereof
03/31/2010CN101683322A Method for preparing nano berberine hydrochloride liposome by supercritical carbon dioxide method
03/30/2010US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
03/30/2010US7687637 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors
03/30/2010US7687607 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLS)
03/30/2010US7687535 Substituted 3-sulfur indoles
03/30/2010US7687507 Protein tyrosine kinase, such as Janus Kinase 3, inhibitors, immunosuppressants; organ transplants, lupus, multiple sclerosis, psoriasis; antidiabetic agents, antiarthritic agents, anticarcinogenic agents, Alzheimer's Disease, Crohn's Disease, Inflammatory Bowel Disease, autoimmune thyroid disorders
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 878